NCT01598922

Brief Summary

The purpose of this study is to understand the effectiveness of a ten-week internet-based cognitive behavioral therapy (iCBT) treatment on improving depressive symptoms, coping and resilience skills, and cognitive processing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for not_applicable major-depressive-disorder

Timeline
Completed

Started Oct 2012

Typical duration for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 15, 2012

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
5.4 years until next milestone

Results Posted

Study results publicly available

December 7, 2020

Completed
Last Updated

May 25, 2021

Status Verified

May 1, 2021

Enrollment Period

2.8 years

First QC Date

May 11, 2012

Results QC Date

March 9, 2017

Last Update Submit

May 3, 2021

Conditions

Keywords

DepressionInternet Cognitive Behavioral TherapyfMRINeuroimaging

Outcome Measures

Primary Outcomes (1)

  • Change From Pre-treatment to Post-treatment (10 Weeks), Measured by the Hamilton Rating Scale for Depression, 17 Item Version (HRSD-17).

    To assess change in severity of depression symptoms. The total score is reported, which is the sum of the ratings of all items and ranges from 0 to 52, with higher scores indicating a worse outcome or greater severity of depression symptoms.

    Measured at the baseline visit and 10 weeks after the baseline visit

Secondary Outcomes (7)

  • Weekly Patient Health Questionnaire (PHQ-9) Score

    Baseline visit, and 10 weeks after baseline visit

  • Weekly Kessler Psychological Distress Scale (K-10) Score

    Week 10 score

  • Improvement From Baseline in Brain Functioning on the Emotional Interference Task (EIT) and the Monetary Incentive Delay Task (MID)

    baseline, 10 weeks

  • Change From Baseline in Positive and Negative Affect Scale (PANAS) Score

    Baseline visit and 10 weeks after baseline visit

  • Change From Baseline in Connor Davidson Resilience Scale (CD-RISC) Score

    Baseline visit, and 10 weeks after baseline visit

  • +2 more secondary outcomes

Study Arms (2)

Internet Cognitive Behavioral Therapy

EXPERIMENTAL

Participants with major depressive disorder receive an 8-week long internet-based cognitive behavioral therapy program.

Behavioral: Internet Cognitive Behavioral Therapy

Monitored Attention Control

NO INTERVENTION

Participants with major depressive disorder receive no treatment but are monitored closely for 8 weeks. Participants in this arm are offered the treatment at the end of the study.

Interventions

8 weeks of online treatment program

Internet Cognitive Behavioral Therapy

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age range between 18 and 45.
  • Subjects must be right handed (as measured by Edinburgh Handedness Inventory).
  • The primary language of the subjects must be English
  • Must have regular access to a computer with internet connection and printer (for potential MDD or MAC participants)
  • DSM-IV criteria for current Major Depressive Episode according to SCID (for enrollment into MDD or MAC groups)
  • Absence of any psychotropic medications for at least 2 weeks (6 weeks for fluoxetine; 6 months for neuroleptics; 2 weeks for benzodiazepines; 2 weeks for any other antidepressants)
  • PHQ-9 score below 5 (for enrollment into HC group)

You may not qualify if:

  • Any history of neurological illness or brain injury
  • Current or past DSM-IV Axis I disorder (for enrollment into HC group)
  • Complicating medical conditions that may influence the outcome of neuropsychological assessment or functional imaging (e.g., HIV)
  • Mixed or left-handedness
  • Abnormal visual acuity that is not corrected by contact lenses
  • Metal within the body, claustrophobia, or other contraindications for MRI
  • Less than 9th grade education
  • Use of illicit drugs within the past year
  • Use of marijuana within the past month
  • Current use of opioid or prescribed stimulant medications
  • History of a psychotic mental illness (schizophrenia or bipolar disorder)
  • Current severe symptoms of depression (total score \> 23 or responding \> 1 to Question 9 for suicidal ideation in the Patient Health Questionnaire-9 Item \[PHQ-9\] (Kroenke et al., 2001))
  • A PHQ-9 score below 10 (for potential MDD or MAC participants)
  • Currently participating in Cognitive Behavior Therapy
  • History of ECT treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Isabelle Rosso

Belmont, Massachusetts, 02478, United States

Location

Related Publications (5)

  • Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther. 2009;38(4):196-205. doi: 10.1080/16506070903318960.

    PMID: 20183695BACKGROUND
  • Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004 Jul 1;351(1):13-22. doi: 10.1056/NEJMoa040603.

    PMID: 15229303BACKGROUND
  • Titov N, Andrews G, Davies M, McIntyre K, Robinson E, Solley K. Internet treatment for depression: a randomized controlled trial comparing clinician vs. technician assistance. PLoS One. 2010 Jun 8;5(6):e10939. doi: 10.1371/journal.pone.0010939.

    PMID: 20544030BACKGROUND
  • Rosso IM, Killgore WD, Olson EA, Webb CA, Fukunaga R, Auerbach RP, Gogel H, Buchholz JL, Rauch SL. Internet-based cognitive behavior therapy for major depressive disorder: A randomized controlled trial. Depress Anxiety. 2017 Mar;34(3):236-245. doi: 10.1002/da.22590. Epub 2016 Dec 23.

  • Webb CA, Olson EA, Killgore WDS, Pizzagalli DA, Rauch SL, Rosso IM. Rostral Anterior Cingulate Cortex Morphology Predicts Treatment Response to Internet-Based Cognitive Behavioral Therapy for Depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Mar;3(3):255-262. doi: 10.1016/j.bpsc.2017.08.005. Epub 2017 Aug 26.

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Results Point of Contact

Title
Dr.Isabelle Rosso
Organization
McLean Hospital

Study Officials

  • Scott L Rauch, MD

    Mclean Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: For the clinical trial there were only 2 arms: MDD and MAC. There were no Healthy Controls in the CBT vs attention monitoring trial; both groups were depressed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
President and Psychiatrist-in-Chief

Study Record Dates

First Submitted

May 11, 2012

First Posted

May 15, 2012

Study Start

October 1, 2012

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

May 25, 2021

Results First Posted

December 7, 2020

Record last verified: 2021-05

Locations